• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Coloplast Launches New Catheter in the U.S.

    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors

    NAMSA Relaunches Medtech Outsourcing Solution

    Rollomatic Inc. Welcomes Joe Kane as CEO

    Alveo Technologies Announces New Executive Leadership
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Medbio LLC

    NDH Medical Inc.

    Fusion Biotec Inc.

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Medbio LLC

    NDH Medical Inc.

    Fusion Biotec Inc.

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    New Microneedle Patch Delivers Medication

    Could painlessly deliver vaccines and cancer medications.

    New Microneedle Patch Delivers Medication
    A new microneedle patch delivers medication to melanomas within one minute (ruler is in centimeters). Image courtesy of Newswise.
    Related CONTENT
    • VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring
    • Bright Future Ahead for Renal Denervation
    • FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients
    • Baxter Begins Collaboration with Amazon Web Services
    • Phillips-Medisize Unveils Aria Smart Autoinjector Platform
    Newswise08.26.19
    Melanoma is a deadly form of skin cancer that has been increasing in the U.S. for the past 30 years. Nearly 100,000 new cases of melanoma are diagnosed every year, and 20 Americans die every day from it, according to the American Academy of Dermatology. Now, researchers have developed a fast-acting skin patch that efficiently delivers medication to attack melanoma cells. The device, tested in mice and human skin samples, is an advance toward developing a vaccine to treat melanoma and has widespread applications for other vaccines.
     
    The researchers will present their findings at the American Chemical Society (ACS) Fall 2019 National Meeting and Exposition. ACS, the world’s largest scientific society, is holding the meeting in San DIego through Thursday. It features more than 9,500 presentations on a wide range of science topics.
     
    “Our patch has a unique chemical coating and mode of action that allows it to be applied and removed from the skin in just a minute while still delivering a therapeutic dose of drugs,” said Yanpu He, a graduate student who helped develop the device. “Our patches elicit a robust antibody response in living mice and show promise in eliciting a strong immune response in human skin.”
     
    Topical ointments can impart medications to the skin, but they can only penetrate a small distance through it. While syringes are an effective drug delivery mode, they can be painful. Syringes can also be inconvenient for patients, leading to noncompliance.
     
    Microneedle patches, prepared with a layer-by-layer (LbL) coating method, are one easy, pain-free way to administer treatment. With the LbL process, researchers coat a surface with molecules of alternating positive and negative charge. For a robust drug film to form on the surface of the patch, every adjacent layer must be strongly attracted to each other and also to the microneedle. “But this attraction makes the entire film very ‘sticky,’” He noted. “Past methods, which have retained this ‘sticky’ nature, can take up to 90 minutes for a sufficient amount of drug to leave the patch and enter the skin.”
     
    Paula T. Hammond, Ph.D., along with her graduate students He, Celestine Hong and other colleagues at the Massachusetts Institute of Technology (MIT), devised a way around this problem. They designed a new pH-responsive polymer with two parts. “The first part contains amine groups that are positively charged at the pH at which we make the microneedles, but that become neutral at the pH of skin,” He said. “The second part contains carboxylic acid groups with no charge when the microneedles are made, but which become negatively charged when the patch is applied to the skin, so there is an overall change in charge from positive to negative.” While sticky negative-positive-negative layers are still required for LbL film construction, the team’s patch quickly switches to repelling negative-negative-negative layers when placed on skin. After the microneedles pierce the skin and implant the LbL drug film beneath the skin, the drug leaves the patch quickly.
     
    Using chicken ovalbumin as a model antigen, the team vaccinated mice with their patches, and compared the results with intramuscular and subcutaneous injections. The microneedle treatment produced nine times the antibody level compared to intramuscular injections (e.g., used for flu shots) and 160 times the antibody level compared to subcutaneous injections (e.g., used for measles vaccines). They also saw efficient immune activation in surgical samples of human skin. 
     
    “Our patch technology could be used to deliver vaccines to combat different infectious diseases,” Hammond said. “But we are excited by the possibility that the patch is another tool in the oncologists’ arsenal against cancer, specifically melanoma.”
     
    To make a melanoma vaccine, the researchers developed an antigen that includes a marker frequently overexpressed by melanoma cells, as well as an adjuvant, which creates a generalized danger signal for the immune system and boosts its response. Then, they tested different LbL microneedle film arrangements of antigen and adjuvant in immune cells derived from mice. From these experiments, the researchers identified the optimal LbL microneedle structure that appears to activate immune cells directly accessible in the skin. In living mice, these cells could, in turn, migrate to the lymphatic system and recruit other immune cells to attack the melanoma tumor. The researchers now plan to test the patches on melanoma tumors in mice. 
     
    “We are using low-cost chemistry and a simple fabrication scheme to transform vaccination,” Hammond commented. “Ultimately, we want to get a device approved and on the market.”
    Related Searches
    • coat
    • skin cancer
    • surgical
    • market
    Suggested For You
    VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring
    Bright Future Ahead for Renal Denervation Bright Future Ahead for Renal Denervation
    FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients
    Baxter Begins Collaboration with Amazon Web Services Baxter Begins Collaboration with Amazon Web Services
    Phillips-Medisize Unveils Aria Smart Autoinjector Platform Phillips-Medisize Unveils Aria Smart Autoinjector Platform
    BioFourmis BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    BD Acquires Velano Vascular BD Acquires Velano Vascular
    DataRobot Launches AI for Health Incubator DataRobot Launches AI for Health Incubator
    Heartbeat Health Raises $20 Million Series B Funding Heartbeat Health Raises $20 Million Series B Funding
    Expanded FDA Approval for Medtronic Expanded FDA Approval for Medtronic's Arctic Front Cryoablation Catheter
    LifeConnect Partners With Movement Interactive and AffirmXH LifeConnect Partners With Movement Interactive and AffirmXH
    Vivasure Medical First Patient in Study of Next-Gen PerQseal+ Device Vivasure Medical First Patient in Study of Next-Gen PerQseal+ Device
    FDA Approves Medtronic FDA Approves Medtronic's SenSight Directional Lead System for DBS
    CeQur Raises $115 Million Series C5 Financing CeQur Raises $115 Million Series C5 Financing
    Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure Abbott Begins Trial for Patients with Simultaneous AFib and Heart Failure

    Related Breaking News

    • Patient Monitoring
      VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring

      VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring

      Brings market-leading patient management and monitoring tools to physicians.
      VitalConnect Inc. 09.16.21

    • Bright Future Ahead for Renal Denervation

      Bright Future Ahead for Renal Denervation

      No devices yet approved in the United States for the high blood pressure treatment.
      GlobalData 09.02.21

    • Neurological
      FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients

      FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients

      Expanded depression indication further demonstrates company’s leadership position.
      GlobeNewswire 08.19.21


    • Digital Health
      Baxter Begins Collaboration with Amazon Web Services

      Baxter Begins Collaboration with Amazon Web Services

      Advancing strategic priorities in digital health, customer experience, and technology modernization.
      Baxter 08.03.21

    • Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Small and easy-to-use injection device is designed to support medication management.
      Phillips-Medisize 08.02.21

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    Breaking News
    • The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    • Coloplast Launches New Catheter in the U.S.
    • Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    • NAMSA Relaunches Medtech Outsourcing Solution
    • Rollomatic Inc. Welcomes Joe Kane as CEO
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Dr. Ranjini Murthy Joins Azelis Americas as SVP of Commercial and Digital Excellence
    Pomegranate Extract Tied to Gut and Skin Microbiome Benefits
    Berry Health Benefits Symposium Includes Panel on Dietary Supplements
    Coatings World

    Latest Breaking News From Coatings World

    EPS Launches New Acrylic DIrect-to-Metal Polymer
    Evonik, Partners Launch PlasCO₂ Project for C4 Chemicals Production
    Masco Corporation Reaches $5 Million Milestone in Grant Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Coloplast Launches New Catheter in the U.S.
    Josh Ghaim and Sachin Jain Join Cue Health Board of Directors
    NAMSA Relaunches Medtech Outsourcing Solution
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer Revenues Soar to Record-Breaking $100B in 2022
    iuvo BioScience Appoints Industry Exec to Lead Lab Biz
    Seqens Opens Flagship R&D Center in Greater Boston
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    U.S. Prestige Beauty Industry Sales Revenue Grew 15% in 2022
    Personal Care Market Forecasted to Grow at CAGR of 6.4% from 2022-2027
    P&G Designs Recyclable Pump Dispenser
    Happi

    Latest Breaking News From Happi

    Nutricosmetics & Wellness Market Expected to Grow 5% by 2033
    Anastasia Beverly Hills Celebrates 25th Anniversary
    Henkel Honors Leading Suppliers During American Cleaning Institute Convention Week
    Ink World

    Latest Breaking News From Ink World

    Early-Bird Registration Opens for Print UV 2023
    Arkema Partners with Research Institute to Open Lab in France
    White Inorganic Pigments Market Worth $29.5 Billion by 2026: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    AWA to host 23rd Global Release Liner Industry Conference & Exhibition
    Color-Logic certifies Ecofoil digital labestock for cut sheet printers
    Brandywine Label Printing names Dave Rosen new president
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ahlstrom Launches New Generation FluoroFree Technology
    Berry to Begin Production at India Healthcare Hub Early This Year
    FiltXPO to be Held in October
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    ODT's Most-Read Stories This Week—Jan. 28
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Textiles are Smarter with Durak SilverPro Conductive Threads
    Arkema Partners with Research Institute to Open Lab in Mulhouse, France
    Veridos to Become Majority Shareholder in NetSeT

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login